RX BioSyent Inc.

12.23USD17.49 CAD · TSXV-1.58%Mkt Cap: 137.33M USDP/E: 20.58

BioSyent Inc., together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the…